Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...

In a wellness landscape crowded with generic solutions, Remedy's Nutrition® shifts the focus to individualized biological ...

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

Why next-generation avionics validation is becoming a value driver for aircraft leases. Avionics are the nervous system of ...

Insufficient architectural integrity is a major AI blocker, forcing many organizations to prioritize speed over foundational ...

In an era where data has become one of the most valuable assets for organizations, protecting that data is a strategic ...

Quasi Robotics announces CE and UKCA certification for its Model C2 AMR, enabling safe commercial deployment across the ...

Taken together, these predictions don’t point to a year of flashy breakthroughs or dramatic reinvention. Instead, 2026 looks ...

SMX’s invisible molecular markers, readers, and digital ledger create material-level identity to support authentication, ...

Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...

Communications strategist Olga González examines why childhood lead poisoning remains one of the United States’ most ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...